Vishnu Chemicals Q2 FY27 consolidated revenue Rs 429.53 cr, PAT up 8.2%
For Q2 FY27, Vishnu Chemicals’ consolidated revenue from operations was Rs 429.53 cr and PAT Rs 35.57 cr, up from Rs 401.15 cr and Rs 32.88 cr a year earlier.
Key takeaways
- Rs 429.53 cr consolidated revenue from operations vs Rs 401.15 cr in Q2 FY26.
- Total income rose to Rs 439.09 cr from Rs 410.52 cr a year earlier.
- Total expenses increased to Rs 390.60 cr vs Rs 364.73 cr in Q2 FY26.
- PBT was Rs 48.49 cr vs Rs 45.79 cr in the corresponding quarter.
- PAT came in at Rs 35.57 cr vs Rs 32.88 cr; EPS at Rs 5.28 vs Rs 4.88.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 429.53 cr | Rs 401.15 cr | +7.1% |
| PAT | Rs 35.57 cr | Rs 32.88 cr | +8.2% |
| EPS | Rs 5.28 | Rs 4.88 | +8.2% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 8.28% of revenue, against 8.20% a year earlier.
• Revenue from operations (Q2 FY27, consolidated): Rs 429.53 cr vs Rs 401.15 cr in Q2 FY26, according to the statement of financial results.
• Total income (Q2 FY27, consolidated): Rs 439.09 cr vs Rs 410.52 cr in Q2 FY26.
• Total expenses (Q2 FY27, consolidated): Rs 390.60 cr vs Rs 364.73 cr in Q2 FY26.
• Cost of materials consumed (Q2 FY27, consolidated): Rs 218.31 cr vs Rs 183.96 cr in Q2 FY26.
• Changes in inventories of finished goods, work-in-progress and stock in trade (Q2 FY27, consolidated): Rs (56.19) cr vs Rs (0.873) cr in Q2 FY26.
• Employee benefits expense (Q2 FY27, consolidated): Rs 21.38 cr vs Rs 17.45 cr in Q2 FY26.
• Finance costs (Q2 FY27, consolidated): Rs 13.81 cr vs Rs 11.54 cr in Q2 FY26.
• Depreciation and amortization expenses (Q2 FY27, consolidated): Rs 11.28 cr vs Rs 10.24 cr in Q2 FY26.
• Other expenses (labelled “Other Expenses” in expenses block, Q2 FY27, consolidated): Rs 0.9471 cr vs Rs 0.8112 cr in Q2 FY26.
• Profit before tax – PBT (Q2 FY27, consolidated): Rs 48.49 cr vs Rs 45.79 cr in Q2 FY26.
• Profit after tax – PAT (Q2 FY27, consolidated): Rs 35.57 cr vs Rs 32.88 cr in Q2 FY26.
• Basic EPS (Q2 FY27, consolidated): Rs 5.28 vs Rs 4.88 in Q2 FY26.
• Diluted EPS (Q2 FY27, consolidated): Rs 5.28 vs Rs 4.88 in Q2 FY26.
In the consolidated statement of financial results for the quarter ended 30-Sep-2026, Vishnu Chemicals Limited reported higher revenue from operations and total income compared with the corresponding quarter ended 30-Sep-2025. Revenue from operations rose to Rs 429.53 cr from Rs 401.15 cr, while total income increased to Rs 439.09 cr from Rs 410.52 cr.
On the cost side, total expenses moved up to Rs 390.60 cr from Rs 364.73 cr. Within this, cost of materials consumed increased to Rs 218.31 cr from Rs 183.96 cr, and employee benefits expense rose to Rs 21.38 cr from Rs 17.45 cr. Finance costs were higher at Rs 13.81 cr versus Rs 11.54 cr, and depreciation and amortization expenses increased to Rs 11.28 cr from Rs 10.24 cr. The line item for change in inventories of finished goods, work-in-progress and stock in trade showed Rs (56.19) cr in Q2 FY27 compared with Rs (0.873) cr in Q2 FY26. The “Other Expenses” line in the expenses block was Rs 0.9471 cr, up from Rs 0.8112 cr a year earlier.
Despite higher expenses, profit before tax edged up to Rs 48.49 cr from Rs 45.79 cr in the year-ago quarter. After total tax expense of Rs 12.93 cr (vs Rs 12.90 cr in Q2 FY26), profit after tax for the period was Rs 35.57 cr, compared with Rs 32.88 cr a year earlier. Basic and diluted earnings per share for the quarter, based on a paid-up equity share capital of Rs 13.46 cr (face value Rs 2 each), were reported at Rs 5.28, up from Rs 4.88 in the corresponding prior period, as per the statement of unaudited consolidated financial results.
Track Vishnu Chemicals Ltd
Cruxal reads every Vishnu Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
